U.S., Jan. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07332858) titled 'First-in-Human Expanded Cohort Study of Intrapleural Administration of TolueneSulfonamide in Patients With Malignant Pleural Effusion' on Dec. 19, 2025.
Brief Summary: This study aims to evaluate the safety of intrapleural injection of TolueneSulfonamide in patients with malignant pleural effusion and to explore its potential effectiveness.
Study Start Date: Jan. 20
Study Type: INTERVENTIONAL
Condition:
Malignant Pleural Effusions (Mpe)
Non Small Cell Lung Cancer
Intervention:
DRUG: Intrapleural administration of TolueneSulfonamide
PTS Administration (One Treatment Cycle):
One treatment cycle is defined as one week. PTS is a...